Srinivas M. Ammisetty, MD
Pulmonary Disease Physician · Stanville, KY
Srinivas M. Ammisetty, MD is a pulmonary disease physician with a practice address in Stanville, Kentucky, and NPI 1689758799, issued on Oct 25, 2006. Check the license (Kentucky 35594, as entered in NPPES) on the Kentucky Board of Medical Licensure; the Medicare figures below come from public CMS files.
- Name
- Srinivas M. Ammisetty
- Credential
- MD
- Primary taxonomy
- Pulmonary Disease Physician 207RP1001X
- License number
- 35594 KY
Self-reported in NPPES; status is on the state search - Practice location
- 9350 US Hwy 23 South, Stanville, KY 41659
- Phone
- (606) 478-1005
- Enumerated
- Oct 25, 2006
- Record last updated
- Apr 7, 2020 (not updated in 6 years: call before relying on the address or phone)
- Fax
- (606) 478-8687
- Medicaid ID
- 65943516 KY
- Entity
- Type 1 · individual
Verify Srinivas M. Ammisetty in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersKentucky Board of Medical Licensure
Search for license 35594Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
91% fewer Medicare Part D claims than the average pulmonary disease physician in 2024
131 Medicare Part D claims for 23 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 17% of claims.
Most prescribed
- Atorvastatin Calcium15 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Pulmonary Disease Physician providers in Kentucky
There are 235 pulmonary disease physician records in Kentucky.
Other pulmonary disease physician records in Kentucky
- Amadeo Abraham, M.D.Louisville, KY1891959441
- Mohamad Abul-Khoudoud, MDPaducah, KY1396710091
- Imama Ahmad, MDLexington, KY1679136196
- Mateen Ahmed, M.DSomerset, KY1922028604
- Muhammad Ahmed, MDRussellville, KY1275525933
- Majdi Al Dliw, M.DLexington, KY1790041069
- Moutaz Al Nabhan, MDLouisville, KY1205853900
- Moayad Al-Sona', MDLexington, KY1245755495
- Mahmood Alam, MDWhitesburg, KY1083669741
- Nishant Allena, MDPaducah, KY1598375818
Common questions
What is Srinivas M. Ammisetty, MD's NPI number?
Srinivas M. Ammisetty, MD's National Provider Identifier (NPI) is 1689758799, issued on Oct 25, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Srinivas M. Ammisetty, MD located?
The NPPES record lists a practice address at 9350 US Hwy 23 South, Stanville, KY, 41659. Phone: (606) 478-1005. Providers update this record themselves, so call before visiting.
How can I verify Srinivas M. Ammisetty, MD's license?
NPPES lists Kentucky license number 35594, as entered by the provider. Search the Kentucky Board of Medical Licensure at https://web1.ky.gov/GenSearch/LicenseSearch.aspx?AGY=5. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Srinivas M. Ammisetty, MD prescribe under Medicare Part D?
In 2024, Srinivas M. Ammisetty, MD had 131 Medicare Part D claims for 23 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.